Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression [Internet]

Review
Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Jan. Report No.: 07-EHC007-EF.

Excerpt

This report summarizes the available evidence on the comparative efficacy, effectiveness, and harms of 12 second-generation antidepressants: bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, mirtazapine, nefazodone, paroxetine, sertraline, trazodone, and venlafaxine in treating patients with MDD, dysthymia, and subsyndromal depression. It also evaluates the comparative efficacy and effectiveness for maintaining remission and for treating accompanying symptoms such as anxiety, insomnia, or neurovegetative symptoms.

Publication types

  • Review

Grants and funding

Prepared for: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services. Contract No. 290-02-0016. Prepared by: RTI International-University of North Carolina Evidence-based Practice Center.